Biogen Celebrates As EPO Upholds Tecfidera Patent

But Firm Warns Of Ongoing Generic Challenges As Biosimilars Growth Muted In Q3

 
• By Dave Wallace
  
Biogen welcomed the EPO’s decision (Shutterstock)

More from Generics

More from Business